U.S. Consumer Durables Stock News

Axogen has reported that the FDA has approved the Biologics License Application for AVANCE, an acellular nerve allograft for treating peripheral nerve discontinuities in adults and children aged one month and older under a biologic regulatory framework. This shift from tissue to biologic classification, with certain indications approved under the FDA’s Accelerated Approval pathway pending confirmatory trials, enhances regulatory rigor and could influence how clinicians, payers, and patients...

If you are wondering whether Catalyst Pharmaceuticals is still attractive at around $23 a share, or if most of the upside is already reflected in the price, you are not alone. Despite a modest slip of 1.4% over the past week, the stock is up 8.2% over the last month, 7.3% year to date and 539.9% over five years, which suggests investors have been steadily re rating its prospects. Recent attention on its expanding rare disease portfolio and ongoing efforts to defend and extend its Firdapse...

Wondering if Kraft Heinz is a quietly mispriced staple or a value trap in plain sight? This breakdown will help you figure out whether today’s share price makes sense for long term investors. Despite being down 18.7% year to date and 14.2% over the last year, Kraft Heinz has seen a modest 3.6% lift over the past month, suggesting sentiment may be starting to stabilize after a tough stretch. Recent headlines have focused on Kraft Heinz reshaping its portfolio and leaning harder into higher...

Wondering if CorMedix at around $10 a share is still a smart bet or if the easy money has already been made? This breakdown will help you figure out whether the current price lines up with the company’s true value. The stock is up 6.9% over the last week and 25.5% year to date, but that comes after a choppy 30 day patch where it slipped 10.6%, a pattern that often reflects shifting views on both its growth runway and risk profile. Recent headlines have focused on CorMedix’s progress in...

DiDi Global Inc. recently reported third-quarter 2025 results showing higher sales of CNY 58,590 million and increased net income of CNY 1,459 million, while also completing a US$286.1 million share repurchase program covering 61,513,739 shares. A key development was the launch of a 24/7 fully unmanned Robotaxi trial in Guangzhou’s Huangpu district, signaling meaningful progress in DiDi’s autonomous driving commercialization efforts. Against this backdrop, we will examine how the fully...

Bloom Energy (BE) has quietly become a magnet for investors trying to make sense of volatile clean-energy names, especially after wild swings over the past month and a strong rebound in the past 3 months. See our latest analysis for Bloom Energy. Despite a choppy year that included a steep 30 day share price return of minus 28.0 percent, Bloom Energy has staged a powerful comeback, with a 90 day share price return of 86.7 percent and a 1 year total shareholder return of 290.0 percent...

Lockheed Martin (LMT) has been drifting lower this month, even as its underlying business keeps grinding forward with steady revenue and profit growth. That disconnect naturally raises the question: is the recent pullback overdone? See our latest analysis for Lockheed Martin. At around $446.8, the latest pullback has left Lockheed Martin with a negative year to date share price return. Its five year total shareholder return above 40% shows the longer term compounding story is still intact,...

In recent days, Concentrix updated its fiscal 2025 outlook, raising revenue guidance while trimming EPS and free cash flow expectations as it steps up AI spending and absorbs higher interest costs from prior acquisitions. At the same time, insider share purchases and a dividend increase to a 3.9% yield suggest management is signaling confidence despite near-term profitability pressure. Next, we’ll examine how heavier AI investment and softer EPS guidance may reshape Concentrix’s existing...

In its recent third-quarter report, Remitly Global beat revenue expectations and posted strong growth in active customers and send volumes, but also reported a declining take rate and flagged rising credit risk amid a weaker economic backdrop. Investor concern focused less on the strong past quarter and more on Remitly’s cautious fourth-quarter revenue outlook, which hinted at slower near‑term growth as the company broadens its product mix and risk exposure. Next, we’ll examine how Remitly’s...

In November 2025, Pitney Bowes Inc. launched tender offers to repurchase up to US$75,000,000 of its 6.70% Notes due 2043 and 5.250% Medium-Term Notes due 2037, with the offers scheduled to expire on December 19, 2025. This move signals an effort to reshape the company’s long-dated debt profile, potentially reducing interest costs while giving management more control over its capital structure. We’ll now consider how Pitney Bowes’ move to repurchase up to US$75,000,000 of long-dated notes...

Berkshire Hathaway (BRK.B) has been quietly grinding higher this month, and that steady move tells you more than any headline. Investors are weighing its valuation against a decade of disciplined capital allocation. See our latest analysis for Berkshire Hathaway. Zooming out, that steady climb sits on top of an 11.6% year to date share price return. A 5 year total shareholder return of 121.4% shows long term compounding momentum remains firmly intact. If Berkshire’s pace has you rethinking...

If you are wondering whether ON Semiconductor is quietly turning into a value opportunity, or if the market is still pricing in too much optimism, this article will walk through what the numbers are really saying. The stock has bounced sharply in the short term, with gains of 15.1% over the last week and 18.4% over the last month, even though it is still down 7.4% year to date and 13.1% over the past year. That move comes against a backdrop of renewed enthusiasm around power management and...

Wondering if PPL is quietly offering value while everyone else is chasing the latest high growth story? You are not alone, and this is exactly the kind of setup where careful valuation work can really pay off. Despite a recent pullback, with the stock down 5.2% over the last week and 4.4% over the last month, PPL is still up 8.2% year to date and 5.6% over the last year, building on solid 3 year and 5 year gains of 33.1% and 44.9% respectively. Recent headlines have focused on PPL's ongoing...

In recent days, Valaris Limited has attracted increased attention as institutional AI-driven trading strategies highlighted strong multi-timeframe signals and identified specific entry, target, and risk-management parameters around the stock. What stands out is how sophisticated, signal-based approaches used by larger traders appear to be shaping broader market sentiment toward Valaris at both near-term and long-term horizons. We’ll now examine how this surge in AI-driven positive trading...

C3.ai (AI) has been grinding through a rough stretch, with the stock down sharply this year even as AI chatter dominates markets. That disconnect is exactly what has many investors rechecking the story. See our latest analysis for C3.ai. Despite a recent 1 week share price return of 6.0 percent and a 1 day bounce that lifted the stock to 15.01 dollars, the 1 year total shareholder return of negative 60.07 percent and 5 year total shareholder return of negative 83.77 percent show that momentum...

Energy Transfer (ET) has quietly lagged the broader market this year, and that underperformance has some income focused investors wondering whether the recent weakness is an opportunity or a warning sign. See our latest analysis for Energy Transfer. That sluggish year to date share price return, alongside a slightly weaker 90 day move, suggests momentum has faded, even though the three and five year total shareholder returns still look impressive for longer term holders. If Energy Transfer’s...

If you have been wondering whether Clorox at around $105 is a contrarian value play or a value trap, you are not alone. That is exactly what we are going to unpack here. The stock is down about 2.4% over the last week, 3.6% over the past month, and a steep 35.0% year to date. This has many investors rethinking both the downside risk and the upside potential. Recent headlines have focused on Clorox navigating a slower demand environment in key categories and working through cost pressures,...

Symbotic Inc. recently filed an omnibus shelf registration to potentially issue up to 48,915,312 shares of Class A common stock, preferred stock, and debt securities, alongside a separate follow-on offering of 10,000,000 common shares, after reporting full-year 2025 revenue of US$2,246.92 million and a net loss of US$16.94 million. The company paired this expanded financing flexibility with guidance for first-quarter fiscal 2026 revenue of US$610 million to US$630 million, even as some...

S&P Global’s decision to shift its credit outlook on AvalonBay Communities (AVB) from stable to positive, paired with a fresh $400 million senior notes offering, gives investors new insight into the REIT’s balance sheet strength and growth plans. See our latest analysis for AvalonBay Communities. Investors seem to be weighing AvalonBay’s stronger balance sheet and upbeat credit outlook against broader REIT headwinds, with a recent 1 month share price return of 3.51 percent but a year to date...

Baidu (BIDU) is turning heads after pushing deeper into custom AI chips, aiming for higher performance and lower power use compared with off the shelf options, a strategic shift with clear competitive implications. See our latest analysis for Baidu. The chip push comes after a strong run, with Baidu’s share price delivering a roughly 15% 90 day gain and a 41.81% year to date share price return, even though its five year total shareholder return is still negative. This suggests momentum is...

In recent days, IREN Limited completed a US$2.00 billion private offering of low‑coupon convertible senior notes due 2032 and 2033 and a roughly US$1.63 billion registered direct equity sale, using the proceeds to repurchase existing 2029 and 2030 convertible notes, fund capped call transactions, and support general corporate purposes. This funding move, coming shortly after IREN’s US$9.70 billion, five‑year AI cloud services agreement with Microsoft, marks a clear shift from...

In late November and early December 2025, Archer Aviation outlined plans for a Miami-area air taxi network linking major airports and key destinations, while also entering an exclusive collaboration with Karem Aircraft to access tiltrotor technology for a dual-use vertical lift platform spanning commercial and defense applications. Together, these developments highlight Archer’s effort to pair real-world urban infrastructure partnerships with advanced VTOL technology, aiming to broaden its...

Avis Budget Group recently posted a strong Q3, with revenue exceeding analyst expectations and returning to growth while continuing to invest in innovation and customer experience. At the same time, the company moved to close loss-making Zipcar UK operations, underscoring a sharper focus on profitability, cost discipline, and long-term efficiency. We'll now explore how Q3’s revenue beat and the decision to close Zipcar’s UK business may reshape Avis Budget Group’s investment...

Recently, McDonald’s faced strong online criticism in the US over an US$8 10-piece McNugget meal and broader concerns about pricing and value, even as it continued rolling out seasonal menu items and marketing collaborations across key markets. This clash between customer frustration over affordability and evidence of resilient sales has sharpened investor focus on how McDonald’s balances value perception with growth. We’ll now examine how this growing backlash over perceived meal...